Aktie A2QPFZ PREDICTIVE ONCOLOGY INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Predictive Oncology Inc.

Aktien

A2QPFZ

US74039M3097

POAI

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 26.04.2024 		% 5 Tage % 1. Jan.
1.51 USD -9.04% Intraday Chart für Predictive Oncology Inc. +29.06% -54.10%
25.04. FUJIFILM Wako Chemicals U.S.A. Corporation und Predictive Oncology kündigen Zusammenarbeit an, um Protein-Interferenzen bei Tests zum Nachweis von bakteriellem Endotoxin bei Biopharmazeutika zu reduzieren CI
01.04. Transcript : Predictive Oncology Inc., Q4 2023 Earnings Call, Apr 01, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Predictive Oncology to Participate in Upcoming Investor Conferences
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024
Predictive Oncology to Participate in Upcoming San Francisco Conferences
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
Predictive Oncology Inc. Announces Chief Financial Officer Changes
Predictive Oncology Inc. Announces Executive Changes
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q2 Revenue $490,110
Predictive Oncology Inc. Reports Impairment Charges for the Second Quarter Ended June 30, 2023
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
Predictive Oncology Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QPFZ Aktie
  4. Nachrichten Predictive Oncology Inc.
  5. Andere Sprachen